SNPs: impact on gene function and phenotype.

Single nucleotide polymorphism (SNP) is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. They may be responsible for the diversity among individuals, genome evolution, the most common familial traits such as curly hair, interindividual differences in drug response, and complex and common diseases such as diabetes, obesity, hypertension, and psychiatric disorders. SNPs may change the encoded amino acids (nonsynonymous) or can be silent (synonymous) or simply occur in the noncoding regions. They may influence promoter activity (gene expression), messenger RNA (mRNA) conformation (stability), and subcellular localization of mRNAs and/or proteins and hence may produce disease. Therefore, identification of numerous variations in genes and analysis of their effects may lead to a better understanding of their impact on gene function and health of an individual. This improved knowledge may provide a starting point for the development of new, useful SNP markers for medical testing and a safer individualized medication to treat the most common devastating disorders. This will revolutionize the medical field in the future. To illustrate the effect of SNPs on gene function and phenotype, this minireview focuses on evidences revealing the impact of SNPs on the development and progression of three human eye disorders (Norrie disease, familial exudative vitreoretinopathy, and retinopathy of prematurity) that have overlapping clinical manifestations.

[1]  A. Monaco,et al.  Isolation of a candidate gene for Norrie disease by positional cloning , 1992, Nature Genetics.

[2]  M. Haasemann,et al.  Norrie disease is caused by mutations in an extracellular protein resembling C–terminal globular domain of mucins , 1992, Nature Genetics.

[3]  M. Jobling,et al.  Isolation and characterization of a candidate gene for Norrie disease , 1992, Nature Genetics.

[4]  T. Meitinger,et al.  Mutations in the candidate gene for Norrie disease. , 1992, Human molecular genetics.

[5]  F. D. Ellis,et al.  X-linked recessive familial exudative vitreoretinopathy. , 1992, American journal of ophthalmology.

[6]  E. Schwinger,et al.  The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11. , 1992, American journal of ophthalmology.

[7]  M. Goldberg,et al.  Identification of a nonsense mutation at codon 128 of the Norrie's disease gene in a male infant. , 1993, Archives of ophthalmology.

[8]  X. Estivill,et al.  Identification of two new missense mutations (K58N and R121Q) in the Norrie disease (ND) gene in two Spanish families. , 1993, Human molecular genetics.

[9]  E. Battinelli,et al.  Norrie disease gene: characterization of deletions and possible function. , 1993, Genomics.

[10]  Chris Sander,et al.  Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure , 1993, Nature Genetics.

[11]  W. Hendrickson,et al.  A structural superfamily of growth factors containing a cystine knot motif , 1993, Cell.

[12]  A. Fielder,et al.  X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis. , 1993, The British journal of ophthalmology.

[13]  X. Breakefield,et al.  Characterization of a mutation within the NDP gene in a family with a manifesting female carrier. , 1993, Human molecular genetics.

[14]  A. Fielder,et al.  A mutation in the Norrie disease gene (NDP) associated with X–linked familial exudative vitreoretinopathy , 1993, Nature genetics.

[15]  E. Stone,et al.  Ocular findings associated with a Cys39Arg mutation in the Norrie disease gene. , 1994, Archives of ophthalmology.

[16]  U Orth,et al.  Mapping of the autosomal dominant exudative vitreoretinopathy locus (EVR1) by multipoint linkage analysis in four families. , 1994, Genomics.

[17]  M. Trese,et al.  Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy. , 1995, Genomics.

[18]  X. Breakefield,et al.  Mutations in the Norrie disease gene , 1995, Human mutation.

[19]  Carlos Beckford,et al.  X-LINKED FAMILIAL EXUDATIVE VITREORETINOPATHY: Report of One Family , 1995, Retina.

[20]  U. Kellner,et al.  Missense mutation (Arg121Trp) in the norrie disease gene associated with X‐linked exudative vitreoretinopathy , 1995, Human mutation.

[21]  T. Meitinger,et al.  Missense mutations in the NDP gene in patients with a less severe course of Norrie disease. , 1995, Human molecular genetics.

[22]  T. Stein,et al.  A novel mutation in the Norrie disease gene predicted to disrupt the cystine knot growth factor motif. , 1995, Human molecular genetics.

[23]  H. Ropers,et al.  An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. , 1996, Human molecular genetics.

[24]  Three novel and two recurrent mutations of the Norrie disease gene in patients with Norrie syndrome , 1996, Human mutation.

[25]  E. Palmer.  The continuing threat of retinopathy of prematurity. , 1996, American journal of ophthalmology.

[26]  R. Trembath,et al.  Familial exudative vitreoretinopathy linked to D11S533 in a large Asian family with consanguinity. , 1996, Ophthalmic genetics.

[27]  R. Ferrell,et al.  X‐linked exudative vitreoretinopathy caused by an arginine to leucine substitution (R121L) in the Norrie disease protein , 1996, Clinical genetics.

[28]  M. Trese,et al.  Identification of novel missense mutations in the Norrie disease gene associated with one X‐linked and four sporadic cases of Familial Exudative Vitreoretinopathy , 1997, Human mutation.

[29]  M. Trese,et al.  Evidence for genetic heterogeneity in X-linked familial exudative vitreoretinopathy. , 1997, Genomics.

[30]  I. Craig,et al.  Two new mutations in exon 3 of the NDP gene: S73X and S101F associated with severe and less severe ocular phenotype, respectively , 1997, Human mutation.

[31]  K. Sims,et al.  Norrie disease in a family with a manifesting female carrier. , 1997, Archives of ophthalmology.

[32]  M. Trese,et al.  Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. , 1997, Archives of ophthalmology.

[33]  P. Vadalà,et al.  Two new missense mutations (A105T and C110G) in the norrin gene in two Italian families with Norrie disease and familial exudative vitreoretinopathy. , 1997, American journal of medical genetics.

[34]  R. Hill,et al.  Norrie Disease Protein (Norrin) Forms Disulfide-linked Oligomers Associated with the Extracellular Matrix* , 1997, The Journal of Biological Chemistry.

[35]  M. Trese,et al.  Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. , 1997, American journal of medical genetics.

[36]  N. Martin,et al.  A twin-pronged attack on complex traits , 1997, Nature Genetics.

[37]  Allen Foster,et al.  Retinopathy of prematurity in middle-income countries , 1997, The Lancet.

[38]  M. Metzker,et al.  Cloning of a novel member of the low-density lipoprotein receptor family. , 1998, Gene.

[39]  Michele D'Urso,et al.  Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity , 1998, Clinical genetics.

[40]  J. Kenyon,et al.  Analysis of the 5' regulatory region of the human Norrie's disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling expression. , 1999, Gene.

[41]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[42]  J. Clayton-Smith,et al.  Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. , 1999, Human molecular genetics.

[43]  M. Trese,et al.  Norrie Disease and Exudative Vitreoretinopathy in Families with Affected Female Carriers , 1999, European journal of ophthalmology.

[44]  A. Brookes.  The essence of SNPs. , 1999, Gene.

[45]  B. Shastry,et al.  Localization of the Norrie disease gene mRNA by in situ hybridization , 1999, Brain Research Bulletin.

[46]  M. Trese,et al.  Linkage and candidate gene analysis of autosomal‐dominant familial exudative vitreoretinopathy , 2000, Clinical genetics.

[47]  U. Tangen,et al.  Investigations into the Molecular Effects of Single Nucleotide Polymorphism , 2001, Pathobiology.

[48]  Barkur S. Shastry and Miki Hiraoka.  Molecular genetics of familial exudative vitreoretinopathy and Norrie disease , 2000 .

[49]  C. Inglehearn,et al.  Genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of the EVR1 locus on chromosome 11q in a large autosomal dominant pedigree , 2000, The British journal of ophthalmology.

[50]  William C. Skarnes,et al.  An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.

[51]  Q. Yuan,et al.  A Single Point Mutation at the 3′-Untranslated Region of Ran mRNA Leads to Profound Changes in Lipopolysaccharide Endotoxin-mediated Responses* , 2001, The Journal of Biological Chemistry.

[52]  N. Niikawa,et al.  Two Thai families with Norrie disease (ND): association of two novel missense mutations with severe ND phenotype, seizures, and a manifesting carrier. , 2001, American journal of medical genetics.

[53]  K. Gregory-Evans,et al.  De novo mutations in the 5′ regulatory region of the Norrie disease gene in retinopathy of prematurity , 2001, Journal of medical genetics.

[54]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[55]  Kenshi Hayashi,et al.  Delineation of the critical interval for the familial exudative vitreoretinopathy gene by linkage and haplotype analysis , 2001, Human Genetics.

[56]  M. Trese,et al.  Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity , 2001, Journal of Human Genetics.

[57]  C. Karp,et al.  A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity1 , 2001, The Journal of Immunology.

[58]  T J Keen,et al.  A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. , 2001, American journal of human genetics.

[59]  H. Rehm,et al.  Vascular Defects and Sensorineural Deafness in a Mouse Model of Norrie Disease , 2002, The Journal of Neuroscience.

[60]  Y. Yu,et al.  Mutations of the Norrie gene in Korean ROP infants. , 2002, Korean journal of ophthalmology : KJO.

[61]  M. Haider,et al.  Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism in Kuwaiti Children with Retinopathy of Prematurity , 2002, Neonatology.

[62]  M. Haider,et al.  A C597-->A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. , 2002, Journal of biomedical science.

[63]  M. Hayden,et al.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy , 2002, Nature Genetics.

[64]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[65]  K Oshima,et al.  Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity , 2003, The British journal of ophthalmology.

[66]  B. Shastry,et al.  Role of SNP/haplotype map in gene discovery and drug development: An overview , 2004 .

[67]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[68]  M. Nakagawa,et al.  Novel mutation at the initiation codon in the Norrie disease gene in two Japanese families , 2004, Human Genetics.

[69]  Ajamete Kaykas,et al.  WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.

[70]  J. Nathans,et al.  Vascular Development in the Retina and Inner Ear Control by Norrin and Frizzled-4, a High-Affinity Ligand-Receptor Pair , 2004, Cell.

[71]  142 Vascular Endothelial Growth Factor Gene Polymorphism and The Risk of Retinopathy of Prematurity , 2004 .

[72]  M. Trese,et al.  Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. , 2004, American journal of human genetics.

[73]  P. S. Klein,et al.  The Frizzled family: receptors for multiple signal transduction pathways , 2004, Genome Biology.

[74]  C. E. Nouhuys.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina , 1982, Documenta Ophthalmologica.

[75]  R. Moon,et al.  Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization , 2004, Nature Cell Biology.

[76]  S. Yoshida,et al.  Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy. , 2004, American journal of ophthalmology.

[77]  Kang Zhang,et al.  Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. , 2004, Investigative ophthalmology & visual science.

[78]  Michael J Parker,et al.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. , 2004, American journal of human genetics.

[79]  Takaaki Hayashi,et al.  Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4mutations (H69Y and C181R) , 2004, Ophthalmic genetics.

[80]  R. Mountford,et al.  Genetic polymorphisms and retinopathy of prematurity. , 2004, Investigative ophthalmology & visual science.

[81]  M. Trese,et al.  Genetic variants of frizzled‐4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity , 2005, Clinical genetics.

[82]  J. Blackledge,et al.  Is Pacific race a retinopathy of prematurity risk factor? , 2005, Archives of pediatrics & adolescent medicine.

[83]  B. Vásárhelyi,et al.  Association of Genetic Polymorphisms of Vascular Endothelial Growth Factor and Risk for Proliferative Retinopathy of Prematurity , 2005, Pediatric Research.

[84]  E. Rappaport,et al.  Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. , 2005, Molecular vision.

[85]  B. Shastry,et al.  Genetic diversity and new therapeutic concepts , 2005, Journal of Human Genetics.

[86]  B. Falsini,et al.  Macular Structure and Function After Intravitreal Triamcinolone Acetonide for Diffuse Diabetic Macular Edema: A Pilot Study Including OCT and Focal ERG , 2005 .

[87]  Comparative genomics on Norrie disease gene. , 2005, International journal of molecular medicine.

[88]  J. Holmes,et al.  Differences between rat strains in models of retinopathy of prematurity. , 2005, Molecular vision.

[89]  C. Grimm,et al.  Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. , 2005, Investigative ophthalmology & visual science.

[90]  B. Vásárhelyi,et al.  Lack of association between insulin-like growth factor I receptor G+3174A polymorphism and retinopathy of prematurity , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[91]  H. Brereton,et al.  Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. , 2005, Investigative ophthalmology & visual science.

[92]  C. Ayuso,et al.  Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR. , 2005, Molecular vision.

[93]  T. Tahira,et al.  Complexity of the genotype–phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes , 2005, Human mutation.

[94]  W. Berger,et al.  Fetal loss in homozygous mutant Norrie disease mice: A new role of Norrin in reproduction , 2005, Genesis.

[95]  S. Russell,et al.  Phenotypic heterogeneity associated with a novel mutation (Gly112Glu) in the Norrie disease protein , 2006, Eye.

[96]  C. Inglehearn,et al.  Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5 , 2006, British Journal of Ophthalmology.

[97]  J. Dickinson,et al.  Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity , 2006, Clinical & experimental ophthalmology.

[98]  L. Ment,et al.  Genetic Susceptibility to Retinopathy of Prematurity , 2006, Pediatrics.

[99]  D. Cooper,et al.  A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview , 2006, Human Genetics.

[100]  B. Shastry,et al.  Lack of association of the VEGF gene promoter (−634 G→C and −460 C→T) polymorphism and the risk of advanced retinopathy of prematurity , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[101]  B. Shastry,et al.  Pharmacogenetics and the concept of individualized medicine , 2006, The Pharmacogenomics Journal.

[102]  M. Trese,et al.  Genetic Evaluation to Establish the Diagnosis of X-Linked Familial Exudative Vitreoretinopathy , 2006, Ophthalmic genetics.

[103]  H. Stewart,et al.  Advanced bilateral persistent fetal vasculature associated with a novel mutation in the Norrie gene , 2006, British Journal of Ophthalmology.

[104]  G. Hime,et al.  WNT/Frizzled signaling in eye development and disease. , 2006, Frontiers in bioscience : a journal and virtual library.

[105]  P. van Wijngaarden,et al.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies , 2007, British Journal of Ophthalmology.

[106]  F. Takahashi‐Yanaga,et al.  The Wnt/β-Catenin Signaling Pathway as a Target in Drug Discovery , 2007 .

[107]  M. Trese,et al.  Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. , 2007, Archives of ophthalmology.

[108]  J. Nathans,et al.  Mutational Analysis of Norrin-Frizzled4 Recognition* , 2006, Journal of Biological Chemistry.

[109]  M. Trese,et al.  A CHARACTERISTIC PHENOTYPIC RETINAL APPEARANCE IN NORRIE DISEASE , 2007, Retina.

[110]  B. Shastry.  SNPs in disease gene mapping, medicinal drug development and evolution , 2007, Journal of Human Genetics.

[111]  T. Tahira,et al.  Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy , 2007, Human Genetics.

[112]  T. Tahira,et al.  Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy. , 2007, Investigative ophthalmology & visual science.

[113]  B. Shastry.  Assessment of the Contribution of Insulin-like Growth Factor I Receptor 3174 G→A Polymorphism to the Progression of Advanced Retinopathy of Prematurity , 2007, European journal of ophthalmology.

[114]  E. Leshinsky‐Silver,et al.  A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms , 2007, American journal of medical genetics. Part A.

[115]  M. Wang,et al.  A model for familial exudative vitreoretinopathy caused by LPR5 mutations. , 2008, Human molecular genetics.

[116]  Tyson A. Clark,et al.  Evaluation of genetic variation contributing to differences in gene expression between populations. , 2008, American journal of human genetics.